Sign in

You're signed outSign in or to get full access.

Joanne T. Medero

About Joanne T. Medero

Independent Board Member of Nuveen S&P 500 Buy-Write Income Fund (BXMX); Class III trustee with current term expiring at the 2027 annual meeting; joined the Nuveen Funds boards in 2021 (year of birth 1954) .
Career spans senior public-policy and legal leadership across BlackRock (Managing Director, Government Relations and Public Policy, 2009–2020; Senior Advisor to the Vice Chairman, 2018–2020), Barclays Global Investors (Global General Counsel and Corporate Secretary), Barclays Group (Global Head of Government Relations and Public Policy), and the CFTC (General Counsel) .
Education: B.A., St. Lawrence University (1975); J.D., George Washington University Law School (1978) .

Past Roles

OrganizationRoleTenureCommittees/Impact
BlackRock, Inc.Managing Director, Government Relations & Public Policy; Senior Advisor to Vice Chairman2009–2020; 2018–2020Public policy and governance focus
Barclays Group (IBIM)Managing Director, Global Head of Government Relations & Public Policy2006–2009Directed legislative and regulatory advocacy for IB/IM/WM businesses
Barclays Global InvestorsManaging Director; Global General Counsel & Corporate Secretary1996–2006Global legal, corporate governance leadership
Orrick, Herrington & Sutcliffe LLPPartner (Derivatives/Financial Markets Regulation)1993–1995Derivatives and market regulation specialization
Commodity Futures Trading CommissionGeneral Counsel1989–1993Senior federal regulatory counsel (derivatives markets)
The White House, Office of Presidential PersonnelDeputy Assoc./Assoc. Director (Legal & Financial Affairs)1986–1989Executive branch personnel policy/oversight
Industry AssociationsChair, SIFMA AMG Steering Committee (2016–2018); Chair, MFA CTA/CPO & Futures Committee (2010–2012)As shownIndustry standards and policy leadership

External Roles

OrganizationRoleTenureNotes
Baltic-American Freedom FoundationDirectorSince 2019Non-profit board service

Board Governance

  • Independence: The board confirms all nominees and current trustees (including Medero) are not “interested persons” of the Funds, Nuveen/TIAA, or affiliates; deemed Independent Board Members .
  • Class/Term: Class III trustee; current term through the 2027 annual meeting; last elected April 12, 2024 .
  • Committee memberships (BXMX complex-wide unitary board):
    • Compliance, Risk Management & Regulatory Oversight Committee (member)
    • Nominating & Governance Committee (member)
    • Investment Committee (member)
    • Not a member of Executive, Dividend, Audit, or Closed-End Fund Committees .
  • Attendance: Each Board Member attended ≥75% of Board and applicable committee meetings in the last fiscal year .

Meeting cadence (BXMX – last fiscal year):

Meeting TypeCount
Regular Board5
Special Board9
Executive Committee5
Dividend Committee10
Compliance, Risk Mgmt & Regulatory Oversight5
Audit Committee14
Nominating & Governance5
Investment Committee4
Closed-End Fund Committee4

Fixed Compensation

Comp structure (Independent Board Members; effective dates shown):

Component2024 Amount (USD)2025 Amount (USD)Notes
Annual retainer350,000 350,000 Effective Jan 1, 2024
Audit Committee membership30,000 35,000 Membership retainer
Compliance Committee membership30,000 35,000 Membership retainer
Investment Committee membership20,000 30,000 Membership retainer
Dividend Committee membership20,000 25,000 Membership retainer
Nominating & Governance membership20,000 25,000 Membership retainer
Closed-End Funds membership20,000 25,000 Membership retainer
Board Chair add’l retainer140,000 150,000 Applies to Chair, not Medero
Committee Chair add’l retainers20,000–30,000 25,000–35,000 By committee

FY2024/last fiscal-year amounts received by Medero:

ItemAmount (USD)
Aggregate compensation from BXMX (S&P Buy-Write)4,079
Total compensation from funds in the Nuveen Fund Complex461,987
Deferred fees credited from BXMX1,418

Additional notes:

  • No retirement or pension plans for directors; a Deferred Compensation Plan allows deferral into notional Nuveen fund “accounts” with lump-sum or 2–20 year distribution options .
  • Ad hoc/special assignment fees apply per policy; expenses allocated across funds .

Performance Compensation

  • No performance-based pay, equity awards (options/PSUs/RSUs), or performance metrics (e.g., TSR/EBITDA targets) are disclosed for Independent Board Members; compensation consists of retainers and fixed fees outlined above .
  • Funds do not maintain director retirement or pension plans; compensation deferrals are elective and investment-tracking only .

Other Directorships & Interlocks

Company/OrganizationPublic/PrivateRoleCommittee roles
Baltic-American Freedom FoundationNon-profitDirector (since 2019)Not disclosed
  • No other public company directorships for Medero are disclosed in the past five years, and she has never been an employee or director of TIAA/Nuveen or affiliates, supporting independence .

Expertise & Qualifications

  • Regulatory/government affairs leadership: Former CFTC General Counsel; led public policy/government relations at BlackRock and Barclays—strong fit for compliance and regulatory oversight .
  • Legal governance expertise: Former Global General Counsel and Corporate Secretary at BGI; derivatives/market regulation specialty as law firm partner .
  • Education: B.A. (St. Lawrence, 1975); J.D. (GW Law, 1978) .
  • Current committee assignments align to risk, governance, and investment oversight (Compliance; Nominating & Governance; Investment) .

Equity Ownership

SecurityDollar Range (12/31/2024)Shares Owned (12/31/2024)Notes
BXMX (S&P Buy-Write)$0 0 Each Board Member’s individual holdings in each fund were <1% outstanding as of 2/18/2025

Ownership policy and alignment:

  • Governance principle: each Board Member is expected to invest (directly or deferred) at least one year of compensation in funds within the Fund Complex .
  • Aggregate “fund complex” dollar-range holdings are disclosed for several trustees; no aggregate entry is shown for Medero in the Appendix A aggregate table .

Governance Assessment

  • Strengths:

    • Independent trustee with no ties to Adviser/parent; regulatory/legal depth enhances committee oversight (especially Compliance and Governance) .
    • Attendance threshold met (≥75% at Board and applicable committees) with a robust cadence of meetings, indicating engagement .
    • Section 16(a) compliance: Funds report directors and officers complied with filing requirements in the last fiscal year .
  • Alignment and pay structure observations:

    • Significant 2024 increase in fixed retainer to $350,000 and higher committee retainers in 2025; may attract scrutiny on cost vs. value, but structure is transparent and uniform across independent trustees .
    • Medero had no direct BXMX holdings as of 12/31/2024; while the board encourages one-year-compensation investment across the complex, BXMX-specific dollar range is $0 and shares owned are 0 (alignment relies on complex-level exposure and/or deferred compensation usage) .
    • Deferred compensation election is in use (BXMX deferrals $1,418 last fiscal year), modestly aligning interests via fund-tracked deferrals .
  • Conflicts/related-party exposure:

    • No related-party transactions disclosed for directors; independence affirmed; Medero is not listed among trustees with interests in companies advised by affiliates under common control with the Adviser (the example shown pertains to another trustee) .
  • RED FLAGS to monitor:

    • BXMX-specific ownership: $0 and 0 shares as of 12/31/2024 could be viewed as lower “skin-in-the-game” at the fund level despite complex-wide ownership expectations .
    • Director retainer step-up and 2025 committee retainer increases—ensure continued disclosure on workload, deliverables, and effectiveness to justify higher fixed compensation .